Cidofovir (Mylan Institutional LLC)
Welcome to the PulseAid listing for the Cidofovir drug offered from Mylan Institutional LLC. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
| NON-PROPRIETARY NAME: | Cidofovir Anhydrous |
| SUBSTANCE NAME: | CIDOFOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-06-03 |
| END MARKETING DATE: | 0000-00-00 |
Cidofovir HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cidofovir from Mylan Institutional LLC |
| LABELER NAME: | Mylan Institutional LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/mL) |
| START MARKETING DATE: | 2013-06-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67457-210_cdf09920-bfe5-407c-921f-f4aefca3e29e |
| PRODUCT NDC: | 67457-210 |
| APPLICATION NUMBER: | ANDA201276 |
Other CIDOFOVIR Pharmaceutical Manufacturers / Labelers:
